FDA approves suzetrigine, a non-opioid painkiller that blocks sodium channels, offering potent relief without addiction risks.

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Vaginismus, an under-studied sexual dysfunction, involves involuntary spasms of pelvic muscles that can be due to physical ...

Scratching isn’t just a bad habit — it’s an immune defense mechanism. While it fuels inflammation, it also helps fight ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The approval of Axsome Therapeutics’ Symbravo for migraine with or without aura came alongside the greenlight for Vertex's ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The internet never sleeps, and neither does its ability to turn deeply personal trauma into comedy. The latest is the "You're So Funny" TikTok trend.